Class II composite restoration technique teaching: A randomised controlled crossover laboratory‐based trial involving a novel ringless sectional matrix technique.
A retrospective analysis of ezrin protein and mRNA expression in breast cancer: Ezrin expression is associated with patient survival and survival of patients with receptor-positive disease.
Autorzy:
Storr SJ; Nottingham Breast Cancer Research Centre, Biodiscovery Institute, University of Nottingham, School of Medicine, Nottingham, UK. Hoskin V; Division of Cancer Biology and Genetics, Queen's Cancer Research Institute, Queen's University, Kingston, Ontario, Canada.; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada. Aiyappa-Maudsley R; Nottingham Breast Cancer Research Centre, Biodiscovery Institute, University of Nottingham, School of Medicine, Nottingham, UK. Ghaffari A; Division of Cancer Biology and Genetics, Queen's Cancer Research Institute, Queen's University, Kingston, Ontario, Canada.; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada. Varma S; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada. Green A; Nottingham Breast Cancer Research Centre, Biodiscovery Institute, University of Nottingham, School of Medicine, Nottingham, UK. Rakha E; Nottingham Breast Cancer Research Centre, Biodiscovery Institute, University of Nottingham, School of Medicine, Nottingham, UK. Ellis IO; Nottingham Breast Cancer Research Centre, Biodiscovery Institute, University of Nottingham, School of Medicine, Nottingham, UK. Greer PA; Division of Cancer Biology and Genetics, Queen's Cancer Research Institute, Queen's University, Kingston, Ontario, Canada.; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada. Martin SG; Nottingham Breast Cancer Research Centre, Biodiscovery Institute, University of Nottingham, School of Medicine, Nottingham, UK.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 May; Vol. 12 (9), pp. 10908-10916. Date of Electronic Publication: 2023 Mar 20.
An international unified approach to reporting and grading invasive breast cancer. An overview of the International Collaboration on Cancer Reporting (ICCR) initiative.
Autorzy:
Ellis IO; Translational Medical Sciences, School of Medicine, The University of Nottingham, Department of Histopathology, City Hospital Campus, Nottingham University Hospitals, Nottingham, UK. Rakha EA; Translational Medical Sciences, School of Medicine, The University of Nottingham, Department of Histopathology, City Hospital Campus, Nottingham University Hospitals, Nottingham, UK. Tse GM; Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Northwest Territories, Hong Kong SAR. Tan PH; Department of Anatomical Pathology, Singapore General Hospital, Singapore.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2023 Jan; Vol. 82 (1), pp. 189-197.
The frequency and clinical significance of centromere enumeration probe 17 alterations in human epidermal growth factor receptor 2 immunohistochemistry-equivocal invasive breast cancer.
Autorzy:
Katayama A; Translational Medical Sciences Unit, School of Medicine, University of Nottingham, Nottingham, UK.; Diagnostic Pathology, Gunma University Graduate School of Medicine, Maebashi, Japan. Starczynski J; Department of Cellular Pathology, University Hospitals Birmingham NHS Foundation Trust, Edgebaston, Birmingham, UK. Toss MS; Translational Medical Sciences Unit, School of Medicine, University of Nottingham, Nottingham, UK. Shaaban AM; Department of Cellular Pathology, University Hospitals Birmingham NHS Foundation Trust, Edgebaston, Birmingham, UK.; Institute of Cancer and Genomic Sciences, The University of Birmingham, Edgebaston, Birmingham, UK. Provenzano E; Department of Histopathology, Cambridge University NHS Foundation Trust, Cambridge, UK. Quinn CM; Department of Histopathology, St. Vincent's University Hospital, Dublin, and School of Medicine, University College Dublin, Dublin, Ireland. Callagy G; Discipline of Pathology, School of Medicine, Lambe Institute for Translational Research, NUI, Galway, Ireland. Purdie CA; Department of Breast Pathology, Ninewells Hospital and Medical School, Dundee, UK. Millican-Slater R; Department of Histopathology, St James's University Hospital, Leeds, UK. Purnell D; Histopathology Department, University Hospitals of Leicester, Leicester, UK. Chagla L; Burney Breast Unit, St Helens and Knowsley Teaching Hospital NHS Trust, Prescot, UK. Oyama T; Diagnostic Pathology, Gunma University Graduate School of Medicine, Maebashi, Japan. Pinder SE; Division of Cancer Studies, King's College London, Guy's Hospital, London, UK. Chan S; Department of Oncology, Nottingham University Hospitals NHS Trust, Nottingham, UK. Ellis I; Translational Medical Sciences Unit, School of Medicine, University of Nottingham, Nottingham, UK.; Department of Histopathology, Nottingham University Hospitals NHS Trust, Nottingham, City Hospital Nottingham, UK. Lee AHS; Department of Histopathology, Nottingham University Hospitals NHS Trust, Nottingham, City Hospital Nottingham, UK. Rakha EA; Translational Medical Sciences Unit, School of Medicine, University of Nottingham, Nottingham, UK.; Department of Histopathology, Nottingham University Hospitals NHS Trust, Nottingham, City Hospital Nottingham, UK.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2022 Oct; Vol. 81 (4), pp. 511-519. Date of Electronic Publication: 2022 Aug 08.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
